Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-25-220843

Chief Medical Officer sold 7,704 shares at $9.77 ($75,268)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Karlin Daniel · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-25 Sale : show line 1 in the form 10b5-1 −7,704 $9.77 $75,268 430,625 D
Open-market sales · 7,704 sh · avg $9.77 · $75,268
Loading xslF345X05/ownership.xml…